SCOTTSDALE, Ariz., April 23, 2009 (GLOBE NEWSWIRE) -- TASER International, Inc. (Nasdaq:TASR), a leading provider of technology solutions and the market leader in electronic control devices (ECDs) today reported financial results for the first quarter of 2009.
Q1 Financial Summary:
-- For the first quarter of 2009 revenues were $24.6 million, an
increase of $2.1 million or 9% over the same quarter of the prior
year.
-- Operations continued to demonstrate improvement, as gross margin
increased to 59.5% in the first quarter of 2009, compared to 56.8%
in the first quarter of 2008, reflecting the Company's continued
focus on production efficiency and cost controls. Sequentially,
gross margins declined primarily due to a change in sales mix from
higher margin ECDs to lower margin cartridges, mostly driven by a
large United Kingdom cartridge order in the first quarter of 2009.
-- Consistent with the Company's strategy announced last year,
research and development expenses increased by $2.1 million, or
99%, in the first quarter of 2009 compared to the same period in
2008, reflecting the Company's ongoing commitment to invest in new
technology and product diversification.
-- Non-GAAP income from operations for the first quarter of 2009,
which excludes stock-based compensation charges and depreciation
and amortization, was $1.1 million compared to $2.5 million for
the first quarter of 2008. GAAP loss from operations was $(1.0)
million for the first quarter of 2009 compared to income from
operations of $1.5 million for the same period in the prior year.
-- Net loss and diluted loss per share for the first quarter of 2009
were $(0.5) million and $(0.01), respectively.
-- The Company generated $10.5 million from operating activities in
the first quarter of 2009 with ending cash and cash equivalents of
$58.3 million and zero debt.
Significant events in the first quarter of 2009 include the following:
1. International sales represented 37% of total net sales for the
quarter, compared to 28% in the fourth quarter of 2008 and 13% in
the first quarter of 2008. Significant shipments during the
quarter included follow-on orders for TASER(r) X26(tm) ECDs and
cartridges to the UK Government and 3,000 TASER ECDs to the
Brazilian National Guard.
2. The Company unveiled its new integrated digital multi-media
evidence management platform -- EVIDENCE.com -- which works in
conjunction with TASER(r) AXON(tm) -- an on-officer tactical
computer and video/audio recorder that captures incidents from the
officer's perspective. Together, we believe the AXON and
EVIDENCE.com system will revolutionize the way law enforcement
safely and securely captures, stores, analyzes, and manages
digital multi-media evidence collected by officers in the field.
3. On March 31, 2009 the Company announced it began selling the TASER(r)
Shockwave(tm) area denial system to tactical law enforcement,
corrections, homeland security, critical infrastructure and
military customers.
4. Five (5) more product liability suits were dismissed during the
quarter, representing at the end of the quarter a total of
eighty-four (84) wrongful death or injury suits that have been
dismissed or judgment entered in favor of the Company.
"Despite the prevailing global economic challenges, TASER International achieved solid sales in the first quarter of 2009, driven by growth from our international customers," said Rick Smith, Chief Executive Officer of TASER International. "Over the past year, we have recruited a world-class Internet services and software development team. Together with our proven hardware development team, they will help transform our company to a full solutions provider, greatly expanding our total available market opportunities in both revenue and by market segment. EVIDENCE.com signifies the first step in this evolution providing a secure evidence storage and collaboration network that will become the network backbone for our future hardware and software products."
The Company will host its first quarter 2009 earnings conference call on Thursday, April 23, 2009 at 11:00 a.m. ET. The conference call is available via web cast and can be accessed on the "Investor Relations" page at www.TASER.com. To access the teleconference, please dial: 1-866-271-0675 or 1-617-213-8892. The pass code is 84783106 for both numbers.
Non-GAAP Measures
To supplement the Company's Statements of Operations presented in accordance with GAAP, we use non-GAAP measures of certain components of financial performance, specifically non-GAAP income from operations. In order for our investors to be better able to compare our current results with those of previous periods, we have shown a reconciliation of GAAP to non-GAAP financial measures. These reconciliations adjust the related GAAP financial measures to exclude stock-based compensation, depreciation and amortization. We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance and liquidity by excluding certain expenses and expenditures that may not be indicative of our "recurring core business operating results," meaning our operating performance excluding non-cash charges, such as stock-based compensation, depreciation and amortization but also discrete cash charges that are infrequent in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal comparisons to our historical performance and liquidity.
About TASER International, Inc. (TASR):
TASER International's products protect life, providing advanced Electronic Control Devices for use in the law enforcement, medical, military, corrections, professional security, and personal protection markets. TASER(r) devices use proprietary technology to incapacitate dangerous, combative, or high-risk subjects who pose a risk to law enforcement officers, innocent citizens, or themselves in a manner that is generally recognized as a safer alternative to other uses of force. TASER technology protects life, and the use of TASER devices dramatically reduces injury rates for police officers and suspects. For more information about TASER technology, please call (800) 978-2737 or visit our website at www.TASER.com.
The TASER International logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2931
Note to Investors
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements, without limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding TASER International, Inc. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such forward-looking statements.
TASER International assumes no obligation to update the information contained in this press release. These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include but are not limited to: (1) market acceptance of our products; (2) our ability to establish and expand direct and indirect distribution channels; (3) our ability to attract and retain the endorsement of key opinion-leaders in the law enforcement community; (4) the level of product technology and price competition for our products; (5) the degree and rate of growth of the markets in which we compete and the accompanying demand for our products; (6) risks associated with rapid technological change and new product introductions; (7) competition; (8) litigation including lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning allegations of deaths and injuries occurring after use of the TASER device and the negative effect this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly operating results; (14) financial and budgetary constraints of prospects and customers; (15) order delays; (16) dependence upon sole and limited source suppliers; (17) negative reports concerning the TASER device; (18) fluctuations in component pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our ability to retain employees; (21) execution and implementation risks of new technology; (22) ramping manufacturing production to meet demand; (23) medical and safety studies; (24) field test results; and (25) other factors detailed in our filings with the Securities and Exchange Commission, including, without limitation, those factors detailed in the Company's Annual Report on Form 10-K and its Form 10-Qs.
The statements made herein are independent statements of TASER International, Inc. The inclusion of any third parties does not represent an endorsement of any TASER International products or services by any such third parties.
For investor relations information please contact Katie Pyra by phone at 480-515-6330 or via email at IR@TASER.com, or Dan Behrendt, Chief Financial Officer of TASER International, Inc., 480-905-2002.
TASER International, Inc.
Statements of Operations
(Unaudited)
For the Three Months Ended
---------------------------
March 31, 2009 March 31, 2008
-------------- --------------
Net Sales $24,604,780 $22,486,504
---------- ----------
Cost of Products Sold:
Direct manufacturing expense 6,904,667 7,571,497
Indirect manufacturing expense 3,070,862 2,151,689
---------- ----------
Total Cost of Products Sold 9,975,529 9,723,186
---------- ----------
Gross Margin 14,629,251 12,763,318
Sales, general and administrative
expenses 11,448,923 9,160,589
Research and development expenses 4,197,969 2,111,648
---------- ----------
Income (loss) from operations (1,017,641) 1,491,081
Interest and other income, net 94,675 501,364
---------- ----------
Income (loss) before provision
(benefit) for income taxes (922,966) 1,992,445
Provision (benefit) for income taxes (455,207) 775,858
---------- ----------
Net income (loss) $ (467,759) $ 1,216,587
========== ==========
Income (loss) per common and common
equivalent shares
Basic $ (0.01) $ 0.02
Diluted $ (0.01) $ 0.02
Weighted average number of common and
common equivalent shares outstanding
Basic 61,832,808 63,328,336
Diluted 61,832,808 65,784,447
TASER International, Inc.
Reconciliation of GAAP to Non-GAAP Financial Measures
(Unaudited)
For the Three Months Ended
--------------------------
March 31, 2009 March 31, 2008
-------------- --------------
GAAP income (loss) from operations $(1,017,641) $ 1,491,081
Stock-based compensation expense (a) 1,375,036 320,467
Depreciation and amortization 715,467 656,879
---------- ----------
Non-GAAP income from operations $ 1,072,862 $ 2,468,427
========== ==========
a) Results include stock-based compensation as follows:
For the Three Months Ended
--------------------------
March 31, 2009 March 31, 2008
-------------- --------------
Cost of Products Sold $ 99,388 $ 58,850
Sales, general and administrative
expenses 814,074 211,611
Research and development expenses 461,574 50,006
---------- ----------
$ 1,375,036 $ 320,467
========== ==========
TASER International, Inc.
Balance Sheets
(Unaudited)
March 31, December 31,
2009 2008
----------- -----------
ASSETS
Current Assets
Cash and cash equivalents $ 58,264,462 $ 46,880,435
Short-term investments -- 2,498,998
Accounts receivable, net 12,307,122 16,793,553
Inventory 10,327,099 13,467,117
Prepaids and other assets 1,942,078 2,528,539
Current deferred income tax asset 9,580,234 9,430,073
----------- -----------
Total Current Assets 92,420,995 91,598,715
Property and equipment, net 28,021,672 27,128,032
Deferred income tax asset 8,826,778 8,826,778
Intangible assets, net 2,497,076 2,447,011
Other long-term assets 11,325 14,970
----------- -----------
Total Assets $131,777,846 $130,015,506
=========== ===========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts payable $ 4,447,071 $ 3,856,961
Accrued liabilities 3,963,962 4,275,907
Current deferred revenue 2,708,854 2,510,645
Customer deposits 344,347 312,686
----------- -----------
Total Current Liabilities 11,464,234 10,956,199
Deferred revenue, net of current portion 5,161,754 4,840,965
Liability for unrecorded tax benefits 1,668,050 1,692,080
----------- -----------
Total Liabilities 18,294,038 17,489,244
----------- -----------
Commitments and Contingencies
Stockholders' Equity
Common stock 639 638
Additional paid-in capital 89,088,433 87,663,129
Treasury stock (14,708,237) (14,708,237)
Retained earnings 39,102,973 39,570,732
----------- -----------
Total Stockholders' Equity 113,483,808 112,526,262
----------- -----------
Total Liabilities and
Stockholders' Equity $131,777,846 $ 130,015,506
=========== ===========
TASER International, Inc.
Selected Statement of Cash Flows Information
(Unaudited)
For the Three Months Ended
March 31, March 31,
2009 2008
---------- ----------
Net income (loss) $ (467,759) $ 1,216,587
Depreciation and amortization 715,467 656,879
Stock-based compensation expense 1,375,036 320,467
Net cash provided by operating activities 10,528,369 659,421
Net cash provided by investing activities 805,389 4,085,809
Net cash provided by financing activities 50,269 171,229
Cash and Cash Equivalents, end of period $58,264,462 $47,717,920